Assignee
LTZ THERAPEUTICS INC
US·0 granted patents·3 pending applications·0 citations·filing 2024–2024
Top patents by PatentIndex Score
3 records- 0166US2025304687A1Multispecific antibodies targeting cd79b/cd3 and the uses thereofLTZ THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0266US2025304679A1Multispecific antibodies targeting cd79b and cd3 and the uses thereofLTZ THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0358US2025129174A1Anti-4-1-1bbxccr8 antibodies and uses thereofLTZ THERAPEUTICS INC·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LTZ THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →